Immage Biotherapeutics Corp.
IMMG · OTC
2/28/2017 | 11/30/2016 | 8/31/2016 | 5/31/2016 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $6 | $1,625 | $18 | $10 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $41 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $42 | $1,669 | $60 | $49 |
| Operating Income | -$44 | -$1,671 | -$62 | -$51 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $44 | $0 | $0 | $0 |
| Pre-Tax Income | -$0 | -$1,671 | -$62 | -$51 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$0 | -$2 | -$62 | -$51 |
| % Margin | – | – | – | – |
| EPS | -0 | -0.011 | -0 | -0 |
| % Growth | 97.3% | -2,700% | -33.3% | – |
| EPS Diluted | -0 | -0.011 | -0 | -0 |
| Weighted Avg Shares Out | 151,745 | 149,571 | 147 | 146,745 |
| Weighted Avg Shares Out Dil | 151,745 | 149,571 | 147 | 146,745 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | -$42 | -$1,669 | -$60 | -$49 |
| % Margin | – | – | – | – |